India Losing Drug Exports To U.S. As China, S. Korea Exports Grow
This article was originally published in PharmAsia News
Executive SummaryIndia's pharmaceutical industry may be losing its reputation as a sector immune to financial crises, a reputation that has been attracting foreign investors. A recent study showed drug exports from India to the United States fell by 37 percent between October and February. The decline contradicts expectations that the emphases by several governments on prescribing generics meant prosperity for the highly fragmented Indian industry. Research shows China and South Korea are growing in exports to the United States while India's is in decline. (Click here for more
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.